![]() Patient is less than 2 months of age – chlorhexidine is to be used with caution in patients less than 2 months of age. ![]() The only allowed contraindications to CHG are the following: Large sterile drape (a large sterile drape covers the patient’s entire body).Skin prep agent has completely dried before insertion.Povidone iodine, alcohol, CHG, or other specified for children Chlorhexidine gluconate (CHG) for patients ≥60 days old unless there is a documented contraindication to CHG.In NHSN for CLIP insertions, adherence to the bundle requires a “Yes” to all of the following: Chlorhexidine gluconate (CHG) must be used for appropriate skin prep adherence prior to central line insertions for all patients ≥ 60 days old unless there is a documented contraindication.ĬLIP Bundle Q4: What is included in the “NHSN CLIP Bundle”? Yes, but only if there is documentation of contraindication to CHG. This may allow identification of necessary quality improvement efforts for these types of insertions.ĬLIP form for non-successful placement Q2: Does a CLIP form need to be completed for every insertion attempt made?Įvery insertion attempt which requires a new site preparation should be entered as a CLIP event in locations reporting CLIP.ĭocumented contraindication to chlorhexidine gluconate (CHG) Q3: Will the system record adherence to appropriate skin prep if povidone iodine was used due to a documented allergy to CHG? Facilities may include emergent placement in the comments field on the CLIP reporting form or may develop a custom field to capture this information, if they wish. All central line insertions that occur in a location that is performing CLIP surveillance must be included in a facility’s CLIP data, regardless of whether it is emergently placed. Emergently placed CLs Q1: Should central line insertions that occur emergently be included in CLIP data?
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |